Abstract
The objective of this report is to explore the balance between serum and synovial fluid levels of interleukin (IL)-18 in children with juvenile idiopathic arthritis (JIA). Blood samples were obtained from 81 children with JIA and 18 control children. Synovial fluid samples were collected from 16 children with oligoarticular JIA. Concentrations of IL-18 were determined using commercial kit. Patients with systemic JIA had higher serum levels of IL-18 than patients with other forms of JIA or control children, both during the active (median, range: 6,240, 1,600–78,750 pg/ml) and inactive (1,615, 513–3,270 pg/ml) phase of disease [analysis of variance (ANOVA), P < 0.05). Levels of IL-18 in sera of children with oligoarticular JIA (255, 89–4,342 pg/ml) were similar to the respective synovial fluid levels (217, 89–1,245 pg/ml). Serum levels of IL-18 were proportional to the erythrocyte sedimentation rate and levels of C-reactive protein, but inversely proportional to the haemoglobin levels. IL-18 appears to be an important mediator of systemic JIA, while it seems of a lesser relevance in pathogenesis of other JIA forms. Therefore, inhibition of IL-18 might be a base for a successful biological therapy for systemic JIA.
This is a preview of subscription content, log in via an institution to check access.
References
Sullivan KA (2005) Inflammation in juvenile idiopathic arthritis. Pediatr Clin N Am 52:335–357
Mangge H, Vojinovic J, Schauenstein K (2002) Do chemokines spark autoimmunity in juvenile and adult rheumatic disease? Immunobiology 206:459–471
Wilkinson N, Jackson G, Gardner-Medwin J (2003) Biologic therapies for juvenile arthritis. Arch Dis Child 88:186–191
de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B (2004) CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443
de Benedetti F, Martini A (2005) Targeting the interleukin 6 receptor: a new treatment for systemic juvenile idiopathic arthritis? Arthritis Rheum 52:687–693
Gracie JA, Robertson SE, McInnes IB (2003) Interleukin-18. J Leukoc Biol 73:213–224
Gracie JA (2004) Interleukin-18 as a potential target in inflammatory arthritis. Clin Exp Immunol 136:402–404
Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991–1994
Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group (2004) Preliminary criteria for clinical remission for selected categories of juvenile idiopathic arthritis. J Rheumatol 31:2290–2294
Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H (2001) Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum 44:550–560
Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K (2002) Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum 46:2539–2541
Liew FY, McInnes IB (2002) Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 61(Suppl 2):ii100–ii102
Scola MP, Thompson SD, Brunner HI, Tsoras MK, Witte D, van Dijk MA, Grom AA, Passo MH, Glass DN (2002) Interferon-y:interleukin 4 ratio and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 29:369–378
Acknowledgement
We thank Roberto Antolović, PhD (PLIVA, Research Institute Ltd, Zagreb, Croatia) for his kind gift of IL-18 kits, Anita Lukić, MD (Zagreb University School of Medicine, Zagreb, Croatia) for critical revision of the manuscript, and Mrs. Maja Rupčić and Ms. Anđelka Đira (Zagreb University Hospital Centre, Zagreb, Croatia) for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jelušić, M., Lukić, I.K., Tambić-Bukovac, L. et al. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis. Clin Rheumatol 26, 1332–1334 (2007). https://doi.org/10.1007/s10067-006-0474-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0474-0